|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | GPIHBP1 Autoantibody ELISA | Amyloid Beta (1-x) ELISA Assay | Anti-Adalimumab (Humira®) ELISA | Anti-Ustekinumab (Stelara®) ELISA | Complement C4d ELISA |
| Citations | | | | | |
| Catalog Number | 27267 | 27729 | TM09009 | TM09036 | COMPL C4d RUO |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Indirect ELISA for the determination of human GPIHBP1 Autoantibody in serum, EDTA-plasma, heparin plasma, and post-heparin EDTA-plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß (1-x) in EDTA-plasma, cerebrospinal fluids, serum, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Adalimumab (Humira®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | The Complement C4d assay is an enzyme-linked immunosorbent assay (ELISA) for the semiquantitative determination of C4d in human plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Progesterone | BACE1 | PSA (Total) | sAPP Total | Phospho Tau (181P) |
| Sample Type | Serum | Brain Extracts, Cultured Cell Lysate | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Cerebrospinal fluids |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 0.008 - 0.50 U/mL | 7.81 to 500 pg/mL | 0 / 5 - 150 ng/mL | Anti-Ustekinumab (Stelara®) | 0 / 5 - 400 ng/mL |
| Sensitivity | 0.05 ng/mL | 0.16 ng/mL | Inquire | 0.06 ng/mL | 1.9 pg/mL |
| Assay Time | 2 hour total incubation time. | Overnight + 1 hr 30 mins (incubation) | 2 hours, 15 min. total incubation time. | 2 hour, 30 min. total incubation time. | 2 hours total incubation time. |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |